UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Level of Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART)

AIDS and behavior, 2015-04, Vol.19 (4), p.601-611

2015

Link zum Volltext

Verfügbarkeit prüfen

T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy

AIDS (London), 2020-01, Vol.34 (1), p.15-24

2020

Link zum Volltext

Verfügbarkeit prüfen

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

PLoS pathogens, 2017-04, Vol.13 (4), p.e1006285-e1006285

2017

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression

Clinical infectious diseases, 2016-12, Vol.63 (12), p.1661-1667

2016

Link zum Volltext

Verfügbarkeit prüfen

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

Clinical infectious diseases, 2021-08, Vol.73 (3), p.e815-e821

2021

Link zum Volltext

Verfügbarkeit prüfen

Suppressed renoprotective purines in COVID-19 patients with acute kidney injury

Scientific reports, 2022-10, Vol.12 (1), p.17353-17353, Article 17353

2022

Link zum Volltext

Verfügbarkeit prüfen

Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV

Journal of acquired immune deficiency syndromes (1999), 2021-08, Vol.87 (5), p.e234

2021

Link zum Volltext

Verfügbarkeit prüfen

TIM-3 signaling contributes to the suppressive capacity of Tregs from people with HIV on antiretroviral therapy

Journal of leukocyte biology, 2023-09, Vol.114 (4), p.368-372

2023

Link zum Volltext

Verfügbarkeit prüfen

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

AIDS (London), 2015-02, Vol.29 (4), p.463-471

2015

Link zum Volltext

Verfügbarkeit prüfen

Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?

AIDS (London), 2018-11, Vol.32 (17), p.2547-2556

2018

Link zum Volltext

Verfügbarkeit prüfen

Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy

AIDS (London), 2017-09, Vol.31 (15), p.2085-2094

2017

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus–Associated Chronic Inflammation

The Journal of infectious diseases, 2020-04, Vol.221 (10), p.1598-1606

2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Advances in T Cell Therapeutic Vaccines for HIV

Frontiers in immunology, 2022-04, Vol.13, p.905836-905836

2022

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy

Journal of acquired immune deficiency syndromes (1999), 2020-12, Vol.85 (5), p.665

2020

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus

Clinical infectious diseases, 2023-09, Vol.77 (6), p.866-874

2023

Link zum Volltext

Verfügbarkeit prüfen

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019

The Journal of infectious diseases, 2022-09, Vol.226 (5), p.766-777

2022

Link zum Volltext

Verfügbarkeit prüfen

Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions

Journal of virology, 2019-03, Vol.93 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

The Journal of infectious diseases, 2021-02, Vol.223 (2), p.225-233

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1–Infected Apoptotic Cells

The Journal of infectious diseases, 2016-05, Vol.213 (9), p.1400-1409

2016

Link zum Volltext

Verfügbarkeit prüfen

MDSC: a new player in HIV immunopathogenesis

AIDS (London), 2012-07, Vol.26 (12), p.1567-1569

2012

Link zum Volltext

Verfügbarkeit prüfen

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

The Journal of clinical investigation, 2019-08, Vol.129 (8), p.3339-3346

2019

Link zum Volltext

Verfügbarkeit prüfen

CD4+CD73+ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression

AIDS (London), 2013-06, Vol.27 (10), p.1545-1555

2013

Link zum Volltext

Verfügbarkeit prüfen

Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART

PloS one, 2010-03, Vol.5 (3), p.e9852-e9852

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(88)
Tagungsberichte
(2)

Sprache

Englisch
(90)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Level of Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART)

T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

Suppressed renoprotective purines in COVID-19 patients with acute kidney injury

Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV

TIM-3 signaling contributes to the suppressive capacity of Tregs from people with HIV on antiretroviral therapy

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?

Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus–Associated Chronic Inflammation

Editorial: Advances in T Cell Therapeutic Vaccines for HIV

Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus

Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019

Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals

Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1–Infected Apoptotic Cells

MDSC: a new player in HIV immunopathogenesis

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

CD4+CD73+ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression

Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART

Suchergebnisse filtern